PL2797579T3 - Kompozycja zawierająca przeciwciała przeciwko glutenowi i garbniki - Google Patents
Kompozycja zawierająca przeciwciała przeciwko glutenowi i garbnikiInfo
- Publication number
- PL2797579T3 PL2797579T3 PL12816646T PL12816646T PL2797579T3 PL 2797579 T3 PL2797579 T3 PL 2797579T3 PL 12816646 T PL12816646 T PL 12816646T PL 12816646 T PL12816646 T PL 12816646T PL 2797579 T3 PL2797579 T3 PL 2797579T3
- Authority
- PL
- Poland
- Prior art keywords
- tannins
- composition
- gluten antibodies
- gluten
- antibodies
- Prior art date
Links
- 229920001864 tannin Polymers 0.000 title 1
- 239000001648 tannin Substances 0.000 title 1
- 235000018553 tannin Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39583—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials not provided for elsewhere, e.g. haptens, coenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ATA50010/2011A AT512342B1 (de) | 2011-12-19 | 2011-12-19 | Zusammensetzung |
| PCT/AT2012/050200 WO2013090965A2 (de) | 2011-12-19 | 2012-12-19 | Zusammensetzung |
| EP12816646.9A EP2797579B1 (de) | 2011-12-19 | 2012-12-19 | Zusammensetzung enthaltend antikörper gegen gluten und gerbstoffe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2797579T3 true PL2797579T3 (pl) | 2019-04-30 |
Family
ID=47598538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12816646T PL2797579T3 (pl) | 2011-12-19 | 2012-12-19 | Kompozycja zawierająca przeciwciała przeciwko glutenowi i garbniki |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US9724326B2 (pl) |
| EP (2) | EP2797579B1 (pl) |
| AT (1) | AT512342B1 (pl) |
| CA (1) | CA2859576C (pl) |
| DK (1) | DK2797579T3 (pl) |
| ES (1) | ES2698904T3 (pl) |
| HK (1) | HK1203392A1 (pl) |
| LT (1) | LT2797579T (pl) |
| PL (1) | PL2797579T3 (pl) |
| PT (1) | PT2797579T (pl) |
| RS (1) | RS58037B1 (pl) |
| WO (1) | WO2013090965A2 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT512342B1 (de) * | 2011-12-19 | 2013-10-15 | Sciotec Diagnostic Technologies Gmbh | Zusammensetzung |
| CN115666546A (zh) | 2020-04-03 | 2023-01-31 | 卢普奥克西治疗公司 | 肠内有氧化疗法 |
| EP4398876A4 (en) | 2021-09-29 | 2025-07-23 | Lpoxy Therapeutics Inc | ENTERIC AEROBIZATION THERAPY |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100392904B1 (ko) * | 2001-01-12 | 2003-07-28 | 매일유업주식회사 | 계란항체 함유 조성물 및 이를 함유하는 식품 |
| US6713096B2 (en) * | 2002-01-04 | 2004-03-30 | Melaleuca, Inc. | Dietary supplements and methods for treating pain and inflammation |
| US20030143293A1 (en) * | 2002-01-31 | 2003-07-31 | Sergei Shushunov | Compositions and methods for treating diarrhea |
| JP2007082469A (ja) * | 2005-09-22 | 2007-04-05 | En Otsuka Pharmaceutical Co Ltd | 口腔ケア用飲食品 |
| JP2010522246A (ja) | 2007-03-27 | 2010-07-01 | ザ プロクター アンド ギャンブル カンパニー | プロバイオティクスを投与するための方法及びキット |
| US8282928B2 (en) | 2007-05-30 | 2012-10-09 | The Governors Of The University Of Alberta | Anti-gluten egg yolk antibodies for the treatment of celiac disease |
| US20100129418A1 (en) * | 2008-11-18 | 2010-05-27 | Lowell Jeffry Lawrence | Method of inducing negative chemotaxis using an ellagitannin or gallotannin |
| AT512342B1 (de) * | 2011-12-19 | 2013-10-15 | Sciotec Diagnostic Technologies Gmbh | Zusammensetzung |
-
2011
- 2011-12-19 AT ATA50010/2011A patent/AT512342B1/de active
-
2012
- 2012-12-19 LT LTEP12816646.9T patent/LT2797579T/lt unknown
- 2012-12-19 PT PT12816646T patent/PT2797579T/pt unknown
- 2012-12-19 US US14/367,171 patent/US9724326B2/en active Active
- 2012-12-19 EP EP12816646.9A patent/EP2797579B1/de active Active
- 2012-12-19 DK DK12816646.9T patent/DK2797579T3/en active
- 2012-12-19 HK HK15104054.8A patent/HK1203392A1/xx unknown
- 2012-12-19 RS RS20181447A patent/RS58037B1/sr unknown
- 2012-12-19 ES ES12816646T patent/ES2698904T3/es active Active
- 2012-12-19 CA CA2859576A patent/CA2859576C/en active Active
- 2012-12-19 WO PCT/AT2012/050200 patent/WO2013090965A2/de not_active Ceased
- 2012-12-19 EP EP18187486.8A patent/EP3424489A1/de not_active Withdrawn
- 2012-12-19 PL PL12816646T patent/PL2797579T3/pl unknown
-
2017
- 2017-06-30 US US15/638,638 patent/US10898464B2/en active Active
-
2020
- 2020-12-22 US US17/130,986 patent/US20210128524A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US10898464B2 (en) | 2021-01-26 |
| PT2797579T (pt) | 2018-12-06 |
| HK1203392A1 (en) | 2015-10-30 |
| US9724326B2 (en) | 2017-08-08 |
| US20170304259A1 (en) | 2017-10-26 |
| WO2013090965A2 (de) | 2013-06-27 |
| CA2859576A1 (en) | 2013-06-27 |
| RS58037B1 (sr) | 2019-02-28 |
| AT512342A1 (de) | 2013-07-15 |
| EP3424489A1 (de) | 2019-01-09 |
| CA2859576C (en) | 2023-05-02 |
| ES2698904T3 (es) | 2019-02-06 |
| US20210128524A1 (en) | 2021-05-06 |
| AT512342B1 (de) | 2013-10-15 |
| WO2013090965A3 (de) | 2013-08-08 |
| US20150017174A1 (en) | 2015-01-15 |
| DK2797579T3 (en) | 2018-12-10 |
| LT2797579T (lt) | 2018-11-26 |
| EP2797579A2 (de) | 2014-11-05 |
| EP2797579B1 (de) | 2018-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288203A (en) | Meditops and Meditop binding antibodies and their use | |
| IL281250A (en) | Anti-PHF-tau antibodies and uses thereof | |
| IL259436A (en) | Antibodies against 3angptl and their uses | |
| IL271305B (en) | Anti-ntb–a antibodies and related compositions and methods | |
| DK2729170T3 (en) | Antibody variants and uses thereof | |
| IL232399A0 (en) | Anti-2fgfr antibodies and their use | |
| EP2756094A4 (en) | ANTI-B7-H4 ANTIBODIES AND USES THEREOF | |
| IL229431A0 (en) | Preparations against cgrp and their use | |
| GB201106357D0 (en) | Composition and uses thereof | |
| GB201106433D0 (en) | Composition and method | |
| PT2797579T (pt) | Composição | |
| GB201112426D0 (en) | Composition and method | |
| GB201102040D0 (en) | Composition and method | |
| GB201111496D0 (en) | Composition and method | |
| GB201116421D0 (en) | Composition and method | |
| GB201117620D0 (en) | Method and composition |